WooGene B&G Co., Ltd (KOSDAQ:018620)
South Korea · Delayed Price · Currency is KRW 2,870.00
+145.00 (5.32%)
At close: Oct 23, 2026
WooGene B&G Market Cap
WooGene B&G has a market cap or net worth of 19.9 billion as of October 23, 2026. It is the 38,817th most valuable company in the world and the 2,419th biggest in South Korea. Its market cap has decreased by 21.73% in one year.
Market Cap
19.90B
Enterprise Value
69.26B
Revenue
56.49B
Global Rank
Country Rank
#2,419 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since May 20, 2008, WooGene B&G's market cap has increased from 18.33B to 19.90B, an increase of 8.57%. That is a compound annual growth rate of 0.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 19.90B | -17.12% |
| Dec 30, 2025 | 24.01B | -6.10% |
| Dec 30, 2024 | 25.57B | -27.76% |
| Dec 28, 2023 | 35.39B | -20.45% |
| Dec 29, 2022 | 44.49B | -26.67% |
| Dec 30, 2021 | 60.66B | -23.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Korean Drug | 32.19B |
| Korea Arlico Pharm | 30.81B |
| HLscience | 27.60B |
| Pharmsville | 26.62B |
| Baskhanbio Pharma | 24.95B |
| Seoul Pharma | 21.80B |
| Daesung Microbiological Labs. | 21.43B |
| Union Korea Pharm | 19.70B |